Jinhe Biotechnology Co., Ltd.
세계 최대의 클로르테트라사이클린 API 생산업체로 사전 혼합된 동물 사료 첨가제도 제조하고 있습니다.
선전 증권 거래소에 상장된 Jinhe Biotechnology는 발효 기반 동물 건강 제품 분야의 글로벌 리더입니다. 이 회사는 80개 이상의 국가에 있는 사료 공장 및 동물 건강 유통업체에 판매되는 수의학 API, 사료 등급 항생제 및 프로바이오틱스를 생산합니다. 60%+ 수출 비율.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Hohhot, China
- Website
- jinhebio.com
- Categories
- 수의학 제품 및 동물 건강, 사료 및 조사료
- Markets
- 미국, 브라질, 인도, 베트남
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
- lei-lapsed (amber), checked 2026-08-12 GLEIF
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)